Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis.

Benabdoun HA, Kulbay M, Rondon EP, Vallières F, Shi Q, Fernandes J, Fahmi H, Benderdour M.

Arthritis Res Ther. 2019 Mar 12;21(1):72. doi: 10.1186/s13075-019-1852-8.

2.

Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.

de Souza RHFV, Picola IPD, Shi Q, Petrônio MS, Benderdour M, Fernandes JC, Lima AMF, Martins GO, Martinez Junior AM, de Oliveira Tiera VA, Tiera MJ.

Int J Biol Macromol. 2018 Nov;119:186-197. doi: 10.1016/j.ijbiomac.2018.07.072. Epub 2018 Jul 18.

PMID:
30031084
3.

In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.

Shi Q, Rondon-Cavanzo EP, Dalla Picola IP, Tiera MJ, Zhang X, Dai K, Benabdoune HA, Benderdour M, Fernandes JC.

Int J Nanomedicine. 2018 Jan 12;13:387-402. doi: 10.2147/IJN.S146942. eCollection 2018.

4.

Deletion of 12/15-lipoxygenase accelerates the development of aging-associated and instability-induced osteoarthritis.

Habouri L, El Mansouri FE, Ouhaddi Y, Lussier B, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H.

Osteoarthritis Cartilage. 2017 Oct;25(10):1719-1728. doi: 10.1016/j.joca.2017.07.001. Epub 2017 Jul 8.

5.

Exacerbation of Aging-Associated and Instability-Induced Murine Osteoarthritis With Deletion of D Prostanoid Receptor 1, a Prostaglandin D2 Receptor.

Ouhaddi Y, Nebbaki SS, Habouri L, Afif H, Lussier B, Kapoor M, Narumiya S, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H.

Arthritis Rheumatol. 2017 Sep;69(9):1784-1795. doi: 10.1002/art.40160. Epub 2017 Aug 1.

6.

An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis.

Abusarah J, Bentz M, Benabdoune H, Rondon PE, Shi Q, Fernandes JC, Fahmi H, Benderdour M.

Inflamm Res. 2017 Aug;66(8):637-651. doi: 10.1007/s00011-017-1044-4. Epub 2017 Apr 26. Review.

PMID:
28447122
7.

Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis.

Abusarah J, Benabdoune H, Shi Q, Lussier B, Martel-Pelletier J, Malo M, Fernandes JC, de Souza FP, Fahmi H, Benderdour M.

J Cell Biochem. 2017 May;118(5):1003-1013. doi: 10.1002/jcb.25659. Epub 2017 Jan 5.

PMID:
27463229
8.

The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis.

Benabdoune H, Rondon EP, Shi Q, Fernandes J, Ranger P, Fahmi H, Benderdour M.

Inflamm Res. 2016 Aug;65(8):635-45. doi: 10.1007/s00011-016-0946-x. Epub 2016 Apr 7.

PMID:
27056390
9.

Cellular Aging, Senescence and Autophagy Processes in Osteoarthritis.

Benderdour M, Martel-Pelletier J, Pelletier JP, Kapoor M, Zunzunegui MV, Fahmi H.

Curr Aging Sci. 2015;8(2):147-57. Review.

PMID:
26212056
10.

Covalent binding of 4-hydroxynonenal to matrix metalloproteinase 13 studied by liquid chromatography-mass spectrometry.

Golizeh M, Abusarah J, Benderdour M, Sleno L.

Chem Res Toxicol. 2014 Sep 15;27(9):1556-65. doi: 10.1021/tx5002095. Epub 2014 Aug 19.

PMID:
25116078
11.

Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.

El Mansouri FE, Nebbaki SS, Kapoor M, Afif H, Martel-Pelletier J, Pelletier JP, Benderdour M, Fahmi H.

Arthritis Res Ther. 2014 May 16;16(3):R113. doi: 10.1186/ar4564.

12.

Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes.

Mongkhon JM, Thach M, Shi Q, Fernandes JC, Fahmi H, Benderdour M.

Inflamm Res. 2014 Aug;63(8):691-701. doi: 10.1007/s00011-014-0742-4. Epub 2014 May 25.

PMID:
24858301
13.

New evidence implicating 4-hydroxynonenal in the pathogenesis of osteoarthritis in vivo.

Shi Q, Abusarah J, Zaouter C, Moldovan F, Fernandes JC, Fahmi H, Benderdour M.

Arthritis Rheumatol. 2014 Sep;66(9):2461-71. doi: 10.1002/art.38704.

14.

Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro.

Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q.

Int J Nanomedicine. 2013;8:4091-102. doi: 10.2147/IJN.S47413. Epub 2013 Oct 31.

15.

Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis' - authors' reply.

Shi Q, Abusarah J, Baroudi G, Fernandes JC, Fahmi H, Benderdour M.

Arthritis Res Ther. 2013 Apr 3;15(2):406. doi: 10.1186/ar4196. No abstract available.

16.

Expression of peroxisome proliferator-activated receptors α, β, γ, and H- and L-prostaglandin D synthase during osteoarthritis in the spontaneous hartley guinea pig and experimental dog models.

Nebbaki SS, El Mansouri FE, Afif H, Kapoor M, Benderdour M, Pelletier JP, Martel-Pelletier J, Fahmi H.

J Rheumatol. 2013 Jun;40(6):877-90. doi: 10.3899/jrheum.120738. Epub 2013 Apr 1.

PMID:
23547214
17.

Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.

Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q.

Int J Nanomedicine. 2012;7:5833-45. doi: 10.2147/IJN.S35567. Epub 2012 Nov 23.

18.

Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis.

Shi Q, Abusarah J, Baroudi G, Fernandes JC, Fahmi H, Benderdour M.

Arthritis Res Ther. 2012 Oct 18;14(5):R223. doi: 10.1186/ar4062.

19.

Inhibition of inducible nitric oxide synthase prevents lipid peroxidation in osteoarthritic chondrocytes.

Bentz M, Zaouter C, Shi Q, Fahmi H, Moldovan F, Fernandes JC, Benderdour M.

J Cell Biochem. 2012 Jul;113(7):2256-67. doi: 10.1002/jcb.24096.

PMID:
22573548
20.

Efficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In Vitro.

Jreyssaty C, Shi Q, Wang H, Qiu X, Winnik FM, Zhang X, Dai K, Benderdour M, Fernandes JC.

ISRN Pharm. 2012;2012:369270. doi: 10.5402/2012/369270. Epub 2012 Mar 7.

21.

Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor γ expression in human osteoarthritic chondrocytes.

Nebbaki SS, El Mansouri FE, Afif H, Kapoor M, Benderdour M, Duval N, Pelletier JP, Martel-Pelletier J, Fahmi H.

Arthritis Res Ther. 2012 Mar 28;14(2):R69. doi: 10.1186/ar3788.

22.
23.

Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression.

Bah TM, Benderdour M, Kaloustian S, Karam R, Rousseau G, Godbout R.

Behav Brain Res. 2011 Nov 20;225(1):243-51. doi: 10.1016/j.bbr.2011.07.039. Epub 2011 Jul 30.

PMID:
21824496
24.

Nuclear receptor retinoid-related orphan receptor α1 modulates the metabolic activity of human osteoblasts.

Benderdour M, Fahmi H, Beaudet F, Fernandes JC, Shi Q.

J Cell Biochem. 2011 Aug;112(8):2160-9. doi: 10.1002/jcb.23141.

PMID:
21480365
25.

Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis.

Shi Q, Wang H, Tran C, Qiu X, Winnik FM, Zhang X, Dai K, Benderdour M, Fernandes JC.

J Biomed Biotechnol. 2011;2011:148763. doi: 10.1155/2011/148763. Epub 2010 Dec 28.

26.

Valproic acid suppresses interleukin-1ß-induced microsomal prostaglandin E2 synthase-1 expression in chondrocytes through upregulation of NAB1.

Zayed N, El Mansouri FE, Chabane N, Kapoor M, Martel-Pelletier J, Benderdour M, Pelletier JP, Duval N, Fahmi H.

J Rheumatol. 2011 Mar;38(3):492-502. doi: 10.3899/jrheum.100907. Epub 2011 Jan 15.

PMID:
21239760
27.

siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis.

Shi Q, Zhang XL, Dai KR, Benderdour M, Fernandes JC.

Expert Opin Biol Ther. 2011 Jan;11(1):5-16. doi: 10.1517/14712598.2010.532483. Epub 2010 Nov 9. Review.

PMID:
21058934
28.

Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis.

El-Bikai R, Welman M, Margaron Y, Côté JF, Macqueen L, Buschmann MD, Fahmi H, Shi Q, Maghni K, Fernandes JC, Benderdour M.

Arthritis Res Ther. 2010;12(5):R201. doi: 10.1186/ar3173. Epub 2010 Oct 26.

29.

Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis.

Vaillancourt F, Silva P, Shi Q, Fahmi H, Fernandes JC, Benderdour M.

J Cell Biochem. 2011 Jan;112(1):107-17. doi: 10.1002/jcb.22884.

PMID:
20872780
30.

Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes.

El Mansouri FE, Chabane N, Zayed N, Kapoor M, Benderdour M, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.

Arthritis Rheum. 2011 Jan;63(1):168-79. doi: 10.1002/art.27762.

31.

Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury.

Hawat G, Benderdour M, Rousseau G, Baroudi G.

Pflugers Arch. 2010 Aug;460(3):583-92. doi: 10.1007/s00424-010-0849-6. Epub 2010 Jun 1.

PMID:
20514543
32.
33.

Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery.

Déry MA, Rousseau G, Benderdour M, Beaumont E.

Neurosci Lett. 2009 Mar 27;453(1):73-6. doi: 10.1016/j.neulet.2009.01.062. Epub 2009 Jan 29.

PMID:
19429019
34.

Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis.

Chabane N, Zayed N, Benderdour M, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.

Arthritis Res Ther. 2009;11(2):R44. doi: 10.1186/ar2652. Epub 2009 Mar 18.

35.

Increased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage.

Zayed N, Li X, Chabane N, Benderdour M, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.

Arthritis Res Ther. 2008;10(6):R146. doi: 10.1186/ar2581. Epub 2008 Dec 18.

36.

Pluronic F-127 as a cell carrier for bone tissue engineering.

Brunet-Maheu JM, Fernandes JC, de Lacerda CA, Shi Q, Benderdour M, Lavigne P.

J Biomater Appl. 2009 Sep;24(3):275-87. doi: 10.1177/0885328208096534. Epub 2008 Nov 5.

PMID:
18987015
37.

An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro.

Fernandes JC, Shi Q, Benderdour M, Lajeunesse D, Lavigne P.

J Bone Miner Metab. 2008;26(6):543-50. doi: 10.1007/s00774-008-0866-0. Epub 2008 Nov 1.

38.

Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.

Zayed N, Afif H, Chabane N, Mfuna-Endam L, Benderdour M, Martel-Pelletier J, Pelletier JP, Motiani RK, Trebak M, Duval N, Fahmi H.

Arthritis Rheum. 2008 Nov;58(11):3530-40. doi: 10.1002/art.23958.

39.

4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase.

Vaillancourt F, Fahmi H, Shi Q, Lavigne P, Ranger P, Fernandes JC, Benderdour M.

Arthritis Res Ther. 2008;10(5):R107. doi: 10.1186/ar2503. Epub 2008 Sep 9.

40.

Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis.

Fernandes JC, Wang H, Jreyssaty C, Benderdour M, Lavigne P, Qiu X, Winnik FM, Zhang X, Dai K, Shi Q.

Mol Ther. 2008 Jul;16(7):1243-51. doi: 10.1038/mt.2008.99. Epub 2008 May 20.

41.

Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.

Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.

Osteoarthritis Cartilage. 2008 Oct;16(10):1267-74. doi: 10.1016/j.joca.2008.03.009. Epub 2008 Apr 15.

42.
43.

Evidence for two distinct pathways in TNFalpha-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients.

Shi Q, Benderdour M, Lavigne P, Ranger P, Fernandes JC.

Osteoarthritis Cartilage. 2007 Mar;15(3):300-8. Epub 2006 Dec 11.

44.

Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal.

Shi Q, Vaillancourt F, Côté V, Fahmi H, Lavigne P, Afif H, Di Battista JA, Fernandes JC, Benderdour M.

Arthritis Res Ther. 2006;8(6):R159.

45.
46.

Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee.

Cheng S, Afif H, Martel-Pelletier J, Benderdour M, Pelletier JP, Hilal G, Haraoui P, Raynauld JP, Choquette D, Fahmi H.

Ann Rheum Dis. 2006 Oct;65(10):1394-7.

47.

Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation.

Morquette B, Shi Q, Lavigne P, Ranger P, Fernandes JC, Benderdour M.

Arthritis Rheum. 2006 Jan;54(1):271-81.

48.

Characterization of folate-chitosan-DNA nanoparticles for gene therapy.

Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, Beaumont E, Fernandes JC.

Biomaterials. 2006 Mar;27(9):2060-5. Epub 2005 Oct 3.

PMID:
16202449
49.

Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases?

Lavigne P, Benderdour M, Shi Q, Lajeunesse D, Fernandes JC.

Expert Opin Biol Ther. 2005 Mar;5(3):313-20. Review.

PMID:
15833069
50.

Subchondral and trabecular bone metabolism regulation in canine experimental knee osteoarthritis.

Lavigne P, Benderdour M, Lajeunesse D, Reboul P, Shi Q, Pelletier JP, Martel-Pelletier J, Fernandes JC.

Osteoarthritis Cartilage. 2005 Apr;13(4):310-7.

Supplemental Content

Loading ...
Support Center